I'm not sure we know which health care companies will negotiate prices, says E Squared's Funtleyder Previous Don't rule out a summer rally for Biotech, says E Squared's Les Funtleyder Next Biotech is going to have a hard time until the end of rate cycle, says E Squared's Les Funtleyder
I'm not sure we know which health care companies will negotiate prices, says E Squared's Funtleyder Previous Don't rule out a summer rally for Biotech, says E Squared's Les Funtleyder Next Biotech is going to have a hard time until the end of rate cycle, says E Squared's Les Funtleyder
